![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
| Item Type: | Article |
|---|---|
| Title: | Recovery from peripartum cardiomyopathy after treatment with bromocriptine |
| Creators Name: | Habedank, D., Kuehnle, Y., Elgeti, T., Dudenhausen, J.W., Haverkamp, W. and Dietz, R. |
| Abstract: | Peripartum cardiomyopathy (PPCM) is a potentially devastating cause of heart failure that affects women late in pregnancy or in early puerperium. Recent findings showed that a 16 kDa fragment of prolactin may induce myocardial damage, and this offered a new option of treating PPCM by blocking prolactin with bromocriptine. We report on a 35-year-old woman with a twin gravidity who gave birth to two healthy boys at day 36/6 and developed a potentially fatal PPCM. Within 3 days since delivery she suffered from severe symptoms of heart failure (orthopnoea, pleural and pericardial effusion, reduced systolic function LVEF 15%). Bromocriptine 2.5 mg bid was added to standard heart failure therapy at day 6 after delivery, and within a week the patient recovered to NYHA functional class II. 2 months later she presented in a good state, NYHA class I, and MRI confirmed an LVEF of 60%. Balancing the potential side effects of bromocriptine against the very poor prognosis in severe PPCM our case supports the use of bromocriptine as a specific novel therapy. |
| Keywords: | Peripartum, Cardiomyopathy, Bromocriptine |
| Source: | European Journal of Heart Failure |
| ISSN: | 1388-9842 |
| Publisher: | Oxford University Press |
| Volume: | 10 |
| Number: | 11 |
| Page Range: | 1149-1151 |
| Date: | November 2008 |
| Official Publication: | https://doi.org/10.1016/j.ejheart.2008.09.001 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
